Generation of novel anti‐apo E monoclonal antibodies that selectively recognize apo E isoforms
FEBS Letters · 2024-04 · 598 (8) · 902-914
DOI: 10.1002/1873-3468.14858 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 26.03.2024. Verfasst von Takashi Ohgita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biophysical Chemistry, Kyoto Pharmaceutical University, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Protein Isoforms, Apolipoproteins E. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Kyoto Pharmaceutical University, Japan Society for the Promotion of Science, Japan Private School Promotion Foundation.
Abstract (Originalsprache)
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biophysical Chemistry, Kyoto Pharmaceutical University, Japan.
- Center for Instrumental Analysis, Kyoto Pharmaceutical University, Japan.
- Laboratory of Bioanalytical Chemistry, Kobe Pharmaceutical University, Japan.
- Laboratory of Pharmacology, Kobe Pharmaceutical University, Japan.
ORCID-Profile: Takashi Ohgita, Hiroyuki Saito
Förderung
- Kyoto Pharmaceutical University
- Japan Society for the Promotion of Science
- Japan Private School Promotion Foundation
Zitieren
APA
Ohgita, T., Sakai, K., Fukui, N., Namba, N., Nakano, M., Kiguchi, Y., Morita, I., Oyama, H., Yamaki, K., Nagao, K., Kobayashi, N., & Saito, H. (2024). Generation of novel anti‐apo E monoclonal antibodies that selectively recognize apo E isoforms. FEBS Letters, 598(8), 902-914. https://doi.org/10.1002/1873-3468.14858
Vancouver
Ohgita T, Sakai K, Fukui N, Namba N, Nakano M, Kiguchi Y, et al. Generation of novel anti‐apo E monoclonal antibodies that selectively recognize apo E isoforms. FEBS Letters. 2024;598(8):902-914. doi:10.1002/1873-3468.14858
BibTeX
@article{Ohgita2024,
author = {Ohgita, Takashi and Sakai, Koto and Fukui, Nodoka and Namba, Norihiro and Nakano, Miyu and Kiguchi, Yuki and Morita, Izumi and Oyama, Hiroyuki and Yamaki, Kouya and Nagao, Kohjiro and Kobayashi, Norihiro and Saito, Hiroyuki},
title = {Generation of novel anti‐apo E monoclonal antibodies that selectively recognize apo E isoforms},
journal = {FEBS Letters},
year = {2024},
volume = {598},
number = {8},
pages = {902--914},
doi = {10.1002/1873-3468.14858}
}
EUVIMED